Thumbnail Image
Item

Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial

Attard, Gerhardt
; 
Sydes, Matthew R.
; 
Mason, Malcolm D.
; 
Clarke, Noel W.
; 
Aebersold, Daniel M
; 
de Bono, Johann S.
; 
Dearnaley, David P.
; 
Parker, Chris C.
; 
Ritchie, Alastair W.S.
; 
Russell, J. Martin
... show 8 more
Authors
Attard, Gerhardt
 Sydes, Matthew R.
 Mason, Malcolm D.
 Clarke, Noel W.
 Aebersold, Daniel M
 de Bono, Johann S.
 Dearnaley, David P.
 Parker, Chris C.
 Ritchie, Alastair W.S.
 Russell, J. Martin
 Thalmann, George
 Cassoly, Estelle
 Millman, Robin
 Matheson, David
 Schiavone, Francesca
 Spears, Melissa R.
 Parmar, Mahesh K.B.
 James, Nicholas D.
Editors
Other contributors
Affiliation
Epub Date
Issue Date
2014-11
Submitted date
Subjects
prostate cancer
 urology
 metastases
 ADT
Show all metadata
Alternative
Abstract
Citation
Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial 2014, 66 (5):799 European Urology
Publisher
Journal
European Urology
Research Unit
URI
http://hdl.handle.net/2436/621049
DOI
10.1016/j.eururo.2014.05.038
PubMed ID
PubMed Central ID
Embedded videos
Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S030228381400520X
Type
Journal article
Language
en
Description
ClinicalTrials.gov identifier NCT00268476
Series/Report no.
ISSN
03022838
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
The Medical Research Council sponsored the study and was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript. Funding was also provided by Cancer Research UK, Astellas, Janssen, Novartis, Sanofi-Aventis, and Pfizer, none of which were directly involved in the research.
Rights
Research Projects
Organizational Units
Journal Issue
Embedded videos
Collections
Faculty of Education, Health and Wellbeing